PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pliant Therapeutics, Inc. (“Pliant” or “the Company”) PLRX for violations of the securities laws. The investigation focuses on whether the Company issued false and/or …